New Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association Conference

FORT MILL, S.C., May 01, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that new clinical data about VIVO is available. Catheter Precision previously announced that data was compiled and presented during three different abstract sessions on its VIVO product. VIVO is a non-invasive mapping system used to identify areas of ventricular arrhythmi ...